Related Experiment Video
Updated: Jul 5, 2026
08:47
Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
Published on: March 3, 2023
House dust mite control measures for asthma
1Rigshospitalet, Dept. 3343, Nordic Cochrane Centre. Blegdamsvej 9, Copenhagen Ø, Denmark, 2100. pcg@cochrane.dk
The Cochrane Database of Systematic Reviews
|April 22, 2008
Summary
Reducing house dust mite allergen exposure through chemical or physical methods does not improve asthma symptoms in sensitive individuals. Further research with rigorous methods is recommended to explore alternative interventions.
Area of Science:
- Allergy and Immunology
- Environmental Health
- Respiratory Medicine
Background:
- House dust mites are a primary allergen triggering asthma in sensitive individuals.
- Interventions aim to reduce mite allergen levels to alleviate asthma symptoms.
Purpose of the Study:
- To evaluate the effectiveness of reducing house dust mite allergen exposure in managing asthma in sensitized patients.
Main Methods:
- Systematic review of 54 randomized controlled trials involving 3002 patients.
- Included trials assessed physical, chemical, or combined mite control measures against placebo or no treatment.
- Data extraction and analysis were performed by two authors, with clarification sought from trial authors.
Main Results:
- No statistically significant improvement in asthma symptoms, peak flow, or medication use was observed with mite allergen reduction methods.
- Analysis of 1565 patients for morning peak flow showed a standardized mean difference of 0.00 (95% CI -0.10 to 0.10).
- No significant differences were found in patient improvement (RR 1.01, 95% CI 0.80 to 1.27) or symptom scores (SMD -0.04, 95% CI -0.15 to 0.07).
Conclusions:
- Current chemical and physical methods for reducing house dust mite allergen exposure are not recommended for asthma management.
- Further research should employ methodologically rigorous designs and novel approaches with careful monitoring of mite exposure and clinical outcomes.
More Related Videos
Related Concept Videos
01:30Asthma-IV: Diagnostic and Management
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
01:29Asthma-I: Introduction
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
01:28Asthma I: Introduction
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
01:20Asthma: Pathogenesis and Management
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
01:30Asthma-IV: Nursing Management
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...